Key result
Aspirin continuation before noncardiac surgery is recommended for patients with cardiac stents unless the bleeding risk outweighs the benefit.
Why the study?
Should aspirin be stopped before noncardiac surgery in patients with cardiac stents or using it for secondary prevention?
Should aspirin be stopped before noncardiac surgery in patients with cardiac stents or using it for secondary prevention?
Aspirin should generally be continued in patients with cardiac stents undergoing noncardiac surgery unless bleeding risks are prohibitive.
Continue aspirin perioperatively in stented patients unless bleeding risk predominates; leaves open precise thresholds for RCTs.
In patients with cardiac stents, do not stop aspirin. If the risk of bleeding outweighs the benefit (eg, with intracranial procedures), an informed discussion involving the surgeon, cardiologist, and patient is critical to ascertain risks vs benefits. In patients using aspirin for secondary
No takes yet. Share an insight, caveat, or question.
Prabhakaran et al. (2019) studied this question. Aspirin continuation before noncardiac surgery is recommended for patients with cardiac stents unless the bleeding risk outweighs the benefit.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: